FDA panel considers easing peptide restrictions
Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the way for easier access.
Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the way for easier access.
This article was originally published at: https://www.npr.org/2026/07/23/nx-s1-5903202/fda-peptides...